Shandong Xinhua Pharmaceutical Co (SZSE:000756) EPS (Basic) : ¥0.74 (TTM As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Shandong Xinhua Pharmaceutical Co EPS (Basic)?

Shandong Xinhua Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Dec. 2023 was ¥0.16. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2023 was ¥0.74.

Shandong Xinhua Pharmaceutical Co's EPS (Diluted) for the three months ended in Dec. 2023 was ¥0.15. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ¥0.72.

Shandong Xinhua Pharmaceutical Co's EPS without NRI for the three months ended in Dec. 2023 was ¥0.18. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was 0.80.

During the past 12 months, Shandong Xinhua Pharmaceutical Co's average EPS without NRIGrowth Rate was 19.60% per year. During the past 3 years, the average EPS without NRI Growth Rate was 12.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was 11.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Shandong Xinhua Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 166.80% per year. The lowest was -57.30% per year. And the median was 11.30% per year.

Shandong Xinhua Pharmaceutical Co EPS (Basic) Historical Data

The historical data trend for Shandong Xinhua Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Xinhua Pharmaceutical Co EPS (Basic) Chart

Shandong Xinhua Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

0.48

0.52

0.56

0.62

0.74

Shandong Xinhua Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EPS (Basic)	Get a 7-Day Free Trial															0.17	0.23	0.17	0.18	0.16

Shandong Xinhua Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Shandong Xinhua Pharmaceutical Co's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(496.512	-	0)	/	670.962
	=	0.74

Shandong Xinhua Pharmaceutical Co's Basic EPS for the quarter that ended in Dec. 2023 is calculated as

Basic EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(104.544	-	0)	/	656.427
	=	0.16

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.74

Shandong Xinhua Pharmaceutical Co (SZSE:000756) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Shandong Xinhua Pharmaceutical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Shandong Xinhua Pharmaceutical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Xinhua Pharmaceutical Co (SZSE:000756) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Xinhua Pharmaceutical Co Ltd (SZSE:000756) » Definitions » EPS (Basic)

Traded in Other Exchanges

00719:Hong Kong XIN:Germany

Address

No. 1 Lutai Avenue, Hi-tech Industry Development Zone, Zibo City, Shandong, CHN, 255086

Website

http://www.xhzy.com

Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It operates the business through the following segments: Chemical bulk drugs, Preparations, Chemical intermediates, and other products. The company provides chemical bulk drug products, including metamizole sodium, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, and L-dopa, it also dispenses formulation products such as compound liquorice tablets and nimodipine tablets. Its products address disorders related to the central nervous system and the cerebrovascular system with the help of antipyretics and analgesics.

Shandong Xinhua Pharmaceutical Co (SZSE:000756) Headlines

No Headlines